Concepedia

Publication | Closed Access

Enhanced Effect of Combined Treatment with SMP-534 (Antifibrotic Agent) and Losartan in Diabetic Nephropathy

DOI

16

Citations

35

References

2006

Year

Eiji Sugaru, Tsutomu Nakagawa, Michiko Ono‐Kishino, Jun Nagamine, Teruhisa Tokunaga, Makoto Kitoh, W. Ewan Hume, Ryu Nagata, Mutsuo Taiji
American Journal of Nephrology

Abstract

A combination of the two agents, SMP-534 and losartan, might be a valuable therapeutic approach for the treatment of diabetic nephropathy.

References

YearCitations

Page 1